Skip to main content
Canna~Fangled Abstracts

Antibacterial effects of cannabigerol on drug-resistant S. iniae

By March 27, 2025April 9th, 2025No Comments
PubMed is a free, comprehensive database of scientific and medical literature, primarily focusing on biomedical and life sciences research. It is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). PubMed is one of the most widely used resources for healthcare professionals, researchers, and students to access peer-reviewed articles, clinical studies, and other scientific publications.

Antibacterial effects of cannabigerol (CBG)

. 2025 Mar 27;207(5):102.

doi: 10.1007/s00203-025-04311-5.

Evaluation of the antibacterial activity and mechanism of cannabigerol against drug-resistant Streptococcus iniae in vitro

Jianing Wu # 1 2, Minmin Wang # 1, Tingke He 1, Xiaonan Li 1, Bowen Liu 1, Fen Chen 1, Yi Geng 1 3, Weiming Lai 1, Xiaoli Huang 4, Defang Chen 4, Ping Ouyang 5 6
Affiliations 

Abstract

This study aimed to investigate the antibacterial effects and mechanism of cannabigerol against drug-resistant Streptococcus iniae. The determination of antibacterial activity was based on the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), growth curve analysis, time-kill assay, biofilm inhibition and eradication assessments. The antibacterial mechanism was explored by DNA leakage assay, assessment of cell membrane permeability, evaluation of cell membrane integrity, measurement of membrane potential, determination of respiratory chain dehydrogenase activity, and examination by using scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The results demonstrated that cannabigerol effectively inhibited the growth and biofilm formation of Streptococcus iniae in vitro. Mechanistically, cannabigerol induced DNA leakage, impaired cell membrane integrity, hyperpolarized membrane potential, and reduced respiratory chain dehydrogenase activity in S. iniae. In conclusion, these findings suggest that cannabigerol inhibited the growth of S. iniae by disrupting the cell membrane.

Keywords: Streptococcus iniae, Antibacterial activity, Antibacterial mechanism, Cannabigerol

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

References

    1. Agnew W, Barnes AC (2007) Streptococcus iniae: an aquatic pathogen of global veterinary significance and a challenging candidate for reliable vaccination. Vet Microbiol 122(1):1–15. https://doi.org/10.1016/j.vetmic.2007.03.002 – DOI – PubMed
    1. Alsheikh-Hussain AS, Zakour B, Forde NL, Rudenko BM, Barnes O, A. C., Beatson SA (2022) A high-quality reference genome for the fish pathogen Streptococcus iniae. Microb Genomics 8(3):000777. https://doi.org/10.1099/mgen.0.000777 – DOI
    1. Aqawi M, Gallily R, Sionov RV, Zaks B, Friedman M, Steinberg D (2020) Cannabigerol prevents quorum sensing and biofilm formation of vibrio harveyi. Front Microbiol 11:858. https://doi.org/10.3389/fmicb.2020.00858 – DOI – PubMed – PMC
    1. Aqawi M, Sionov RV, Gallily R, Friedman M, Steinberg D (2021) Anti-Bacterial properties of Cannabigerol toward Streptococcus mutans. Front Microbiol 12:656471. https://doi.org/10.3389/fmicb.2021.656471 – DOI – PubMed – PMC
    1. Bai J, Li J, Chen Z, Bai X, Yang Z, Wang Z, Yang Y (2023) Antibacterial activity and mechanism of clove essential oil against foodborne pathogens. LWT 173:114249. https://doi.org/10.1016/j.lwt.2022.114249 – DOI

MeSH terms

Substances

LinkOut – more resources

Stay informed with the latest scientific insights, evidence-based independent research and discoveries on the ECS, cannabis medicine and more

Revolutionary Research on the ECS, cannabinoids and cannabis-based medicine for healthcare from a trusted nonprofit.

Leave a Reply